Capital International Sarl’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.3M | Sell |
53,819
-16,315
| -23% | -$8.57M | 0.54% | 55 |
|
|
2025
Q1 | $44.5M | Buy |
70,134
+5,099
| +8% | +$3.23M | 1.01% | 26 |
|
|
2024
Q4 | $46.3M | Buy |
65,035
+10,846
| +20% | +$7.73M | 1.07% | 24 |
|
|
2024
Q3 | $57M | Buy |
54,189
+7,053
| +15% | +$7.41M | 1.46% | 15 |
|
|
2024
Q2 | $49.5M | Buy |
47,136
+6,718
| +17% | +$7.06M | 1.51% | 14 |
|
|
2024
Q1 | $38.9M | Buy |
40,418
+9,279
| +30% | +$8.93M | 1.29% | 15 |
|
|
2023
Q4 | $27.3M | Buy |
31,139
+3,071
| +11% | +$2.7M | 1.02% | 21 |
|
|
2023
Q3 | $23.1M | Sell |
28,068
-2,716
| -9% | -$2.24M | 1.06% | 21 |
|
|
2023
Q2 | $22.1M | Buy |
30,784
+3,148
| +11% | +$2.26M | 0.99% | 21 |
|
|
2023
Q1 | $22.7M | Buy |
27,636
+2,969
| +12% | +$2.44M | 1.15% | 18 |
|
|
2022
Q4 | $17.8M | Buy |
24,667
+2,815
| +13% | +$2.03M | 1.25% | 13 |
|
|
2022
Q3 | $15.1M | Buy |
21,852
+2,218
| +11% | +$1.53M | 1.22% | 15 |
|
|
2022
Q2 | $11.6M | Buy |
19,634
+1,601
| +9% | +$946K | 0.93% | 18 |
|
|
2022
Q1 | $12.6M | Buy |
18,033
+5,819
| +48% | +$4.06M | 0.62% | 43 |
|
|
2021
Q4 | $7.71M | Buy |
12,214
+9,748
| +395% | +$6.16M | 0.37% | 83 |
|
|
2021
Q3 | $1.49M | Sell |
2,466
-137
| -5% | -$82.9K | 0.13% | 150 |
|
|
2021
Q2 | $1.45M | Sell |
2,603
-5
| -0.2% | -$2.79K | 0.13% | 160 |
|
|
2021
Q1 | $1.23M | Buy |
2,608
+53
| +2% | +$25.1K | 0.12% | 159 |
|
|
2020
Q4 | $1.23M | Buy |
2,555
+292
| +13% | +$141K | 0.13% | 147 |
|
|
2020
Q3 | $1.27M | Buy |
2,263
+106
| +5% | +$59.3K | 0.16% | 128 |
|
|
2020
Q2 | $1.35M | Buy |
2,157
+611
| +40% | +$381K | 0.18% | 116 |
|
|
2020
Q1 | $755K | Buy |
+1,546
| New | +$755K | 0.14% | 131 |
|